Related Experiment Video
Updated: Aug 9, 2026

Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft
Published on: September 15, 2023
The optimal revascularization strategy for multivessel coronary artery disease: the debate continues
1Interventional Cardiology, Denver Veterans Affairs Medical Center, Colorado 80220, USA. ivan.casserly@med.va.gov
Insights
Mortality rates were lower for coronary artery bypass grafting (CABG) than percutaneous coronary intervention (PCI) in multivessel coronary artery disease patients. This registry finding contrasts with randomized trials showing equivalent outcomes, raising questions about treatment choices.
Area of Science:
- Cardiology
- Health Services Research
Background:
- Coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) are primary revascularization strategies for coronary artery disease (CAD).
- Previous randomized controlled trials (RCTs) indicated similar mortality rates between CABG and PCI for multivessel CAD.
- Real-world data may offer different perspectives on comparative effectiveness.
Purpose of the Study:
- To compare the long-term mortality outcomes of CABG versus PCI in patients with multivessel coronary artery disease using a large state registry.
- To investigate potential discrepancies between observational data and RCT findings in CAD treatment outcomes.
Main Methods:
- Analysis of New York State patient registry data.
- Comparison of mortality rates between patients undergoing CABG and those undergoing PCI for multivessel CAD.
- Statistical adjustment for patient characteristics and comorbidities.
Main Results:
- Patients with multivessel CAD who underwent CABG experienced lower mortality rates compared to those who underwent PCI.
- This finding contrasts with the established results from major randomized controlled trials.
Conclusions:
- Observational data from state registries suggest a potential survival benefit for CABG over PCI in multivessel CAD.
- Further investigation is warranted to reconcile the differences between registry data and RCT findings.
- Clinical decision-making for multivessel CAD revascularization requires careful consideration of evidence from diverse sources.
Abstract:
Mortality rates were lower among patients with multivessel coronary artery disease who underwent coronary artery bypass grafting (CABG) than among similar patients who underwent percutaneous coronary intervention (PCI) in an analysis of data from New York State registries (N Engl J Med 2005; 352:2174-2183). This finding appears to run counter to the results of randomized controlled trials, which found both procedures equivalent with regard to mortality. What are we to believe?
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Atherosclerosis III: Management
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Acute Coronary Syndrome III: Diagnostic Studies
Coronary Artery Disease II: Pathophysiology
Peripheral Artery Disease III: Interprofessional Care